Published in J Clin Pharmacol on March 01, 1992
Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol (2011) 1.06
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies. Indian J Clin Biochem (2011) 0.93
Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke. J Stroke (2015) 0.83
Use of novel oral anticoagulant agents in atrial fibrillation: current evidence and future perspective. Cardiovasc Diagn Ther (2014) 0.81
Use of novel oral anticoagulant agents in venous thromboembolism. Cardiovasc Diagn Ther (2016) 0.79
Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration. Am J Case Rep (2014) 0.77
Study on Impact of Clinical Pharmacist's Interventions in the Optimal Use of Oral Anticoagulants in Stroke Patients. Indian J Pharm Sci (2013) 0.77
Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review. Am J Cardiovasc Drugs (2016) 0.75
Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc (2006) 0.75
Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol (1991) 0.78
Low molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics. J Clin Pharmacol (1991) 0.76